3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
17
Lung Neoplasms
6
Head and Neck Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Kidney Neoplasms
4
Waldenstrom Macroglobulinemia
3
Stomach Neoplasms
3
Skin Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Liver Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Sezary Syndrome
2
Sarcoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
pembrolizumab
2
Semaxinib
2
Nivolumab
2
Docetaxel
2
tin etiopurpurin
1
entinostat
1
daromun
1
cabozantinib
1
Tumor Necrosis Factor-alpha
1
Therapeutics
1
Thalidomide
1
SUB1 protein, human
1
Ritonavir
1
Quality of Life
1
Psychiatric Rehabilitation
1
Patient Reported Outcome Measures
1
Palliative Care
1
Nutritional Support
1
Nelfinavir
1
Molecular Diagnostic Techniques
1
Interleukin-12
1
Immunotherapy
1
Gemcitabine
1
Filgrastim
1
Drug Therapy
1
Celecoxib
1
Brentuximab Vedotin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Kaposi
×
Drug Therapy
×
Dermatologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled